Sangamo Biosciences reported $28.56M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Bayer BAYN:GR € 9781M 1073M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Biogen BIIB:US $ 2778.9M 3.9M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Merk MRK:US $ 13154M 1752M
Novartis NOVN:VX SF 13367M 73M
Omeros OMER:US $ 30M 1.18M
Pfizer PFE:US $ 24094M 5117M
Regulus Therapeutics RGLS:US $ 0M 0M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M